| Trial ID: | L1720 |
| Source ID: | NCT00454350
|
| Associated Drug: |
Hectorol (Doxercalciferol Injection)
|
| Title: |
A Phase 4 Pharmacokinetic Study of Hectorol Injection and Zemplar Injection in CKD Subjects on Hemodialysis
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Secondary Hyperparathyroidism
|
| Interventions: |
DRUG: Hectorol (doxercalciferol injection)|DRUG: Zemplar (Paricalcitol injection)
|
| Outcome Measures: |
Primary: Pharmacokinetic Study, 44 hour interval |
|
| Sponsor/Collaborators: |
Sponsor: Genzyme, a Sanofi Company
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
12
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2007-02
|
| Completion Date: |
2007-07
|
| Results First Posted: |
|
| Last Update Posted: |
2015-05-05
|
| Locations: |
Minneapolis, Minnesota, United States
|
| URL: |
https://clinicaltrials.gov/show/NCT00454350
|
